首页> 外文期刊>Advanced drug delivery reviews >Tissue-engineered 3D tumor angiogenesis models: Potential technologies for anti-cancer drug discovery
【24h】

Tissue-engineered 3D tumor angiogenesis models: Potential technologies for anti-cancer drug discovery

机译:组织工程3D肿瘤血管生成模型:抗癌药物发现的潜在技术

获取原文
获取原文并翻译 | 示例

摘要

Angiogenesis is indispensable for solid tumor expansion, and thus it has become a major target of cancer research and anti-canter therapies. Deciphering the arcane actions of various cell populations during tumor angiogenesis requires sophisticated research models, which could capture the dynamics and complexity of the process. There is a continuous need for improvement of existing research models, which engages interdisciplinary approaches of tissue engineering with life sciences. Tireless efforts to develop a new model to study tumor angiogenesis result in innovative solutions, which bring us one step closer to decipher the dubious nature of cancer. This review aims to overview the recent developments, current limitations and future challenges in three-dimensional tissue-engineered models for the study of tumor angiogenesis and for the purpose of elucidating novel targets aimed at anti-cancer drug discovery. (C) 2014 Elsevier B.V. All rights reserved.
机译:血管生成对于实体肿瘤膨胀是必不可少的,因此它已成为癌症研究和抗慢慢疗法的主要目标。 在肿瘤血管生成期间解入各种细胞群的奥术作用需要复杂的研究模型,这可以捕捉过程的动态和复杂性。 持续改进现有研究模型的改进,与生命科学的组织工程互学科方法汇谈。 制定新模型的不懈努力研究肿瘤血管生成导致创新解决方案,这使我们更接近破译癌症的可疑性质。 该审查旨在概述最近的三维组织工程模型的最新发展,当前局限和未来挑战,用于研究肿瘤血管生成,并阐明旨在抗癌药物发现的新靶点。 (c)2014 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号